MedTrace Logo

Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease

NCT03983408 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-06-09

No results posted yet for this study

Summary

The objective of a randomized, double-blind, placebo-controlled trial and open-label extension study is to figure out the impact of Korean Red Ginseng (KRG) on fatigue in patients with rheumatic diseases.

Conditions

  • Sjögren's Syndrome
  • Rheumatic Diseases
  • Korean Red Ginseng

Interventions

DIETARY_SUPPLEMENT

Korean Red Ginseng

Participants are provided with 2 Korean Red Ginseng extract tablets twice a day for total 24 weeks.

DIETARY_SUPPLEMENT

Placebo

Placebo tablets, made of corn starch and cellulose, are manufactured to mimic KRG tablets. Participants are parovided with 2 placebo tablets twice a day for first 12 weeks, following Korean Red Ginseng extract tablets twice a day for another 12 weeks.

Sponsors & Collaborators

  • The Korean Society of Ginseng

    collaborator OTHER

  • Hanyang University

    lead OTHER

Principal Investigators

  • Yoon-Kyoung Sung, MD, PhD, MPH · Hanyang University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-17
Primary Completion
2020-08-31
Completion
2020-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03983408 on ClinicalTrials.gov